Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03180879Phase 1Completed
Phase 1, randomised, open-label trial of ibuprofen in pain, fever and inflammation (6 arms), sponsored by Reckitt. Primary endpoints: Area Under the Plasma Concentration Curve from Administration to Last Quantifiable Concentration and Maximum Observed Plasma Concentration. Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03180879.